Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2020 | 06-2019 | 06-2017 | 06-2007 | |
| Operating Expenses | 9,151 | 9,542 | 0 | 0 |
| Operating Income | -9,151 | -9,542 | N/A | N/A |
| Other Income | 212 | 294 | 0 | 0 |
| Pre-tax Income | -8,939 | -9,249 | 0 | 0 |
| Net Income Continuous | -8,939 | -9,249 | N/A | N/A |
| Net Income | $-8,939 | $-9,249 | $N/A | $N/A |
| EPS Basic Total Ops | -855.00 | -890.00 | N/A | N/A |
| EPS Basic Continuous Ops | -856.08 | -890.63 | N/A | N/A |
| EPS Diluted Total Ops | -855.00 | -890.00 | N/A | N/A |
| EPS Diluted Continuous Ops | -856.08 | -890.63 | N/A | N/A |
| EBITDA(a) | $-9,038 | $-9,423 | $N/A | $N/A |